Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now
Quote Panel
Key Metrics
Fundamentals
Relative Strength
GSTC
Sector
Top 5 RS in Group
Symbol | Company | RS | 5-Day Perf. |
|---|---|---|---|
Forecast
Analyst rating
Last analyst upgrade/downgrade
accesswire.com
8 hours ago
accesswire.com
8 hours ago
accesswire.com
9 hours ago
Earnings Growth
YoY
Current
Estimates
Q1.22
N/A
-0.00
vs -0.00
Q2.22
N/A
-0.00
vs -0.01
Q3.22
N/A
-0.00
vs -0.01
Q4.22
N/A
-0.00
vs -0.00
Q1.23
N/A
-0.00
vs -0.00
Q2.23
N/A
-0.00
vs -0.00
Q3.23
N/A
-0.00
vs -0.00
Q4.23
N/A
-0.00
vs -0.00
Q1.24
N/A
-0.00
vs -0.00
Q2.24
N/A
-0.00
vs -0.00
Sales Growth
YoY
Current
Estimates
Q1.22
NA
NA vs NA
Q2.22
NA
NA vs NA
Q3.22
-100%
NA vs 4.8K
Q4.22
NA
NA vs NA
Q1.23
NA
NA vs NA
Q2.23
NA
NA vs NA
Q3.23
NA
NA vs NA
Q4.23
NA
NA vs NA
Q1.24
NA
NA vs NA
Q2.24
NA
NA vs NA
Return on Equity
QoQ
Q1.22
+64%
0.64
vs 0.37
Q2.22
+16%
0.16
vs 0.64
Q3.22
+26%
0.26
vs 0.16
Q4.22
+13%
0.13
vs 0.26
Q1.23
+12%
0.12
vs 0.13
Q2.23
+100%
1
vs 0.12
Q3.23
+24%
0.24
vs 1
Q4.23
+11%
0.11
vs 0.24
Q1.24
+12%
0.12
vs 0.11
Q2.24
+12%
0.12
vs 0.12
Institutionnal Ownership
QoQ
Q4.21
2
2
vs 3
-33%
Q1.22
2
2
vs 2
NA
Q2.22
NA
NA
vs NA
NA
Q3.22
NA
NA
vs NA
NA
Q4.22
2
2
vs NA
NA
Q1.23
1
1
vs 2
-50%
Q2.23
1
1
vs 1
NA
Q3.23
1
1
vs 1
NA
Q4.23
1
1
vs 1
NA
Q1.24
1
1
vs 1
NA
Relative Strength
GSTC
Sector
Top 5 RS in Group
Symbol | Company | RS | 5-Day Perf. |
|---|---|---|---|
Quote Panel
Key Metrics
GlobeStar Therapeutics Corporation, a clinical stage pharmaceutical company, focuses on developing a patented formulation of drugs for the treatment of multiple sclerosis and other neurodegenerative diseases. The company was formerly known as AngioSoma, Inc. and changed its name to GlobeStar Therapeutics Corporation in July 2021. The company was incorporated in 2016 and is based in Richland, Washington.
OTC
Unprofitable
EPS improving
Unprofitable
EPS improving
Relative Strenght
Volume Buzz
-87%
Earning Acce
No
Dist 52w H.
80%Forecast
2025-Revenue
2025-EPS
2025-EBITDA
Analyst rating
Strong Sell
Sell
Buy
Neutral
Strong Buy
Price Target
N/A(N/A)
Number of analyst
N/A
Last analyst upgrade/downgrade
No Data Available
